Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1079/bjn20051451.
Affiliations
- PMID: 16277782
- DOI: 10.1079/bjn20051451
Free article
Randomized Controlled Trial
Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life
Astrid M Bakker-Zierikzee et al. Br J Nutr. 2005 Nov.
Free article
Abstract
Adding prebiotics or probiotics to infant formula to improve the intestinal flora of formula-fed infants is considered to be a major innovation. Several companies have brought relevant formulations onto the market. However, comparative data on the effects of pre- and probiotics on the intestinal microflora of infants are not available. The present study aimed to compare the effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the composition and metabolic activity of the intestinal microflora. Before birth, infants were randomised and double blindly allocated to one of three formulas. The prebiotic (GOS/FOS) group (n 19) received regular infant formula supplemented with a mixture of galacto-oligosaccharides and fructo-oligosaccharides (6 g/l). The probiotic (Bb-12) group (n 19) received the same formula supplemented with 6.0x10(10) viable cells of B. animalis per litre. The standard group (n 19) received non-supplemented regular formula. A group of sixty-three breast-fed infants was included as a reference group. Faecal samples were taken at postnatal day 5 and 10, and week 4, 8, 12 and 16. Compared with the groups fed Bb-12 and standard formula, the GOS/FOS formula group showed higher faecal acetate ratio (69.7 % (sem 2.7), 69.9 % (sem 3.9) and 82.2 % (sem 5.3); P<0.05) and lactate concentration (11.3 (sem 7.9), 3.1 (sem 2.3) and 34.7 (sem 10.7) mmol/kg faeces) and lower pH (6.6 (sem 0.2), 7.1 (sem 0.2) and 5.6 (sem 0.2); P<0.05) at 16 weeks. Differences in percentage of bifidobacteria between the GOS/FOS (59.2 % (sem 7.7)), Bb-12 (52.7 % (sem 8.0)) and the standard (51.8 % (sem 6.4)) groups were not statistically significant at 16 weeks. Feeding infants GOS/FOS formula resulted in a similar effect on metabolic activity of the flora as in breast-fed infants. In the Bb-12 group, composition and metabolic activity of the flora were more similar to those of the standard group.
Similar articles
- Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants.
Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schöpfer H, Böckler HM, Wells J. Knol J, et al. J Pediatr Gastroenterol Nutr. 2005 Jan;40(1):36-42. doi: 10.1097/00005176-200501000-00007. J Pediatr Gastroenterol Nutr. 2005. PMID: 15625424 Clinical Trial. - Faecal SIgA secretion in infants fed on pre- or probiotic infant formula.
Bakker-Zierikzee AM, Tol EA, Kroes H, Alles MS, Kok FJ, Bindels JG. Bakker-Zierikzee AM, et al. Pediatr Allergy Immunol. 2006 Mar;17(2):134-40. doi: 10.1111/j.1399-3038.2005.00370.x. Pediatr Allergy Immunol. 2006. PMID: 16618363 Clinical Trial. - Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH.
Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V. Fanaro S, et al. J Pediatr Gastroenterol Nutr. 2005 Aug;41(2):186-90. doi: 10.1097/01.mpg.0000172747.64103.d7. J Pediatr Gastroenterol Nutr. 2005. PMID: 16056097 Clinical Trial. - Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review.
Fanaro S, Boehm G, Garssen J, Knol J, Mosca F, Stahl B, Vigi V. Fanaro S, et al. Acta Paediatr Suppl. 2005 Oct;94(449):22-6. doi: 10.1111/j.1651-2227.2005.tb02150.x. Acta Paediatr Suppl. 2005. PMID: 16214761 Review. - Prebiotics in infant formulas.
Boehm G, Jelinek J, Stahl B, van Laere K, Knol J, Fanaro S, Moro G, Vigi V. Boehm G, et al. J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S76-9. doi: 10.1097/01.mcg.0000128927.91414.93. J Clin Gastroenterol. 2004. PMID: 15220664 Review.
Cited by
- Effectiveness and safety study of formula containing probiotics, prebiotics, synbiotics on fullterm infants' growth - a systematic review and meta-analysis of randomized controlled study.
Qian J, Fang Z, Chang S, Zeng Z, Zhang J. Qian J, et al. Eur J Clin Nutr. 2024 Oct 24. doi: 10.1038/s41430-024-01506-9. Online ahead of print. Eur J Clin Nutr. 2024. PMID: 39448812 Review. - Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon.
Ziemons J, Hillege LE, Aarnoutse R, de Vos-Geelen J, Valkenburg-van Iersel L, Mastenbroek J, van Geel R, Barnett DJM, Rensen SS, van Helvoort A, Dopheide LHJ, Roeselers G, Penders J, Smidt ML, Venema K. Ziemons J, et al. BMC Microbiol. 2024 Jun 26;24(1):222. doi: 10.1186/s12866-024-03384-4. BMC Microbiol. 2024. PMID: 38918717 Free PMC article. - Effects of neonatal nutrition interventions on neonatal mortality and child health and development outcomes: A systematic review.
Imdad A, Rehman F, Davis E, Ranjit D, Surin GSS, Attia SL, Lawler S, Smith AA, Bhutta ZA. Imdad A, et al. Campbell Syst Rev. 2021 Mar 5;17(1):e1141. doi: 10.1002/cl2.1141. eCollection 2021 Mar. Campbell Syst Rev. 2021. PMID: 37133295 Free PMC article. Review. - Health Effects of Infant Formula Supplemented with Probiotics or Synbiotics in Infants and Toddlers: Systematic Review with Network Meta-Analysis.
Indrio F, Gutierrez Castrellon P, Vandenplas Y, Cagri Dinleyici E, Francavilla R, Mantovani MP, Grillo A, Beghetti I, Corvaglia L, Aceti A. Indrio F, et al. Nutrients. 2022 Dec 5;14(23):5175. doi: 10.3390/nu14235175. Nutrients. 2022. PMID: 36501205 Free PMC article. Review. - Breastfeeding Affects Concentration of Faecal Short Chain Fatty Acids During the First Year of Life: Results of the Systematic Review and Meta-Analysis.
Łoniewski I, Skonieczna-Żydecka K, Stachowska L, Fraszczyk-Tousty M, Tousty P, Łoniewska B. Łoniewski I, et al. Front Nutr. 2022 Jul 11;9:939194. doi: 10.3389/fnut.2022.939194. eCollection 2022. Front Nutr. 2022. PMID: 35898706 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical